Depressive Disorders Notes

Depressive and Bipolar Disorders: Introduction to Depressive Disorders

Depression is a mood state characterized by feelings of sadness, loss of interest or pleasure, and decreased energy. It is a common mental disorder that can affect how you feel, think, and behave. Mania, the opposite of depression, is characterized by elevated mood, increased energy, and often unrealistic optimism. It is primarily associated with bipolar disorder. Depressive disorders encompass a range of conditions, including Major Depressive Disorder (MDD), Persistent Depressive Disorder (dysthymia), and Premenstrual Dysphoric Disorder (PMDD). Unipolar depression involves recurrent depressive episodes without any history of manic or hypomanic episodes, whereas bipolar disorder is characterized by alternating periods of depressive and manic episodes.

Prevalence of Depression

Depression is a widespread issue, affecting millions of people worldwide. In the United States, approximately 8% of adults receive a diagnosis and treatment for depression each year, with an additional 5% experiencing milder forms of the disorder. It is estimated that around 20% of adults will experience depression at some point in their lives. The typical age of onset for depression is around 19 years old, although it can occur at any age.

Symptoms of Depression

The symptoms of depression can vary from person to person, but they generally fall into several categories:

  • Emotional: Persistent low mood, feelings of sadness, emptiness, or hopelessness. Also includes feelings of guilt, worthlessness, and self-reproach.

  • Motivational: Significant fatigue, lack of energy, reduced motivation to engage in activities, and loss of interest or pleasure in things that were once enjoyable.

  • Behavioral: Noticeable slowing down of motor movements (psychomotor retardation) or, conversely, restlessness and agitation. Social withdrawal and isolation are also common.

  • Cognitive: Negative thoughts about oneself, the world, and the future. Difficulty concentrating, remembering things, and making decisions. Thoughts of death or suicide.

  • Physical: Changes in appetite (either increased or decreased), significant weight loss or gain, sleep disturbances (insomnia or hypersomnia), body aches, headaches, digestive problems, and other physical complaints.

DSM-5 Depressive Disorders

The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), outlines specific criteria for diagnosing depressive disorders:

  • Major Depressive Disorder (MDD): Characterized by one or more major depressive episodes. A major depressive episode involves a period of at least two weeks during which a person experiences a persistently depressed mood or loss of interest or pleasure in nearly all activities.

  • Persistent Depressive Disorder (Dysthymia): A chronic form of depression characterized by a persistently depressed mood that lasts for at least two years in adults (or one year in children and adolescents).

  • Premenstrual Dysphoric Disorder (PMDD): A severe form of premenstrual syndrome (PMS) characterized by significant mood symptoms, such as depression, anxiety, irritability, and mood swings, that occur in the week before menstruation and improve within a few days after menstruation begins.

Criteria for Major Depressive Disorder

To meet the criteria for Major Depressive Disorder, an individual must experience a two-week period of depressed mood or loss of interest or pleasure in nearly all activities, accompanied by at least five of the following symptoms:

  • Significant weight loss when not dieting or weight gain (e.g., a change of more than 5% of body weight in a month), or decrease or increase in appetite nearly every day.

  • Insomnia (difficulty falling asleep or staying asleep) or hypersomnia (sleeping too much) nearly every day.

  • Psychomotor agitation (observable restlessness) or retardation (slowing down of thought and physical movement) nearly every day.

  • Fatigue or loss of energy nearly every day.

  • Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day.

  • Diminished ability to think or concentrate, or indecisiveness, nearly every day.

  • Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.

These symptoms must cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. Additionally, a diagnosis of Major Depressive Disorder requires the absence of any manic or hypomanic episodes.

Persistent Depressive Disorder

Persistent Depressive Disorder, also known as dysthymia, is characterized by a chronic state of negativity and depressed mood that lasts for at least two years in adults (or one year in children and adolescents). While the symptoms may not be as severe as those of Major Depressive Disorder, they are persistent and can significantly impact a person's quality of life. Individuals with Persistent Depressive Disorder may experience:

  • Poor appetite or overeating.

  • Insomnia or hypersomnia.

  • Low energy or fatigue.

  • Low self-esteem.

  • Poor concentration or difficulty making decisions.

  • Feelings of hopelessness.

Unlike Major Depressive Disorder, Persistent Depressive Disorder does not necessarily lead to suicidal thoughts, but it can increase the risk of developing Major Depressive Disorder.

Stress and Depression

Stress plays a significant role in the development and course of depression. Studies have shown that approximately 80% of severe depressive episodes occur within a month or two of a significant negative life event, such as the loss of a loved one, a job loss, or a major illness. Stressful events can trigger the onset of depression in vulnerable individuals. Reactive depression, also known as situational depression, develops in response to identifiable traumatic or stressful events. On the other hand, endogenous depression appears to be biologically driven and heritable, with no clear external trigger.

Genetic Factors of Depression

Genetics play a significant role in the development of endogenous depression. Studies have shown that 25% to 35% of the risk of developing depression is attributable to genetic factors. Individuals with a parent who has depression have a 25% to 35% chance of developing it themselves, compared to about 9% in the general population. However, it is important to note that genetics are not the sole determinant of depression, and environmental factors also play a crucial role.

Biological Factors

Several biological factors have been implicated in the pathophysiology of depression. Low activity of neurotransmitters like serotonin and norepinephrine is associated with depressive symptoms. These neurotransmitters play a crucial role in regulating mood, sleep, appetite, and other functions. Excessive stress can affect the hypothalamic-pituitary-adrenal (HPA) axis, leading to dysregulation of cortisol levels. This dysregulation increases the correlation between PTSD and depression.

Biology of Depression

Brain imaging studies have revealed that individuals with depression often exhibit brain circuit dysfunction, particularly in the subgenual cingulate, a brain region involved in emotional processing and regulation. Irregular activity and blood flow in the brain, along with structural problems in areas like the hippocampus, amygdala, and prefrontal cortex, can contribute to depressive symptoms. Neurotransmitter irregularities, especially with serotonin and norepinephrine, are significant factors in the development of depression.

Depression and the Immune System

Depression, especially when coupled with high stress levels, can have a detrimental impact on the immune system. Chronic stress and depression can suppress immune function, making individuals more susceptible to infections and illnesses. Additionally, inflammation has been implicated in the pathophysiology of depression, with elevated levels of inflammatory markers observed in some individuals with depression.

Treatments for Depression

A variety of treatments are available for depression, including:

  • Antidepressant medications

  • Psychotherapy

  • Brain stimulation techniques

Antidepressant drugs are the most commonly prescribed medications in the United States for the treatment of depression. Initial treatment often involves a combination of antidepressant drugs and psychotherapy, with brain stimulation techniques considered if these approaches are ineffective.

Antidepressant Medications

Newer antidepressant drugs, such as Prozac and selective serotonin reuptake inhibitors (SSRIs), work by increasing the availability of serotonin and norepinephrine in the brain. It typically takes 2 to 4 weeks for the effects of these medications to become noticeable. Common SSRIs include Prozac, Zoloft, and Lexapro, while other antidepressants, such as Effexor, also incorporate norepinephrine. However, research indicates that only about 8% of people with mild to moderate depression experience significant help from these drugs compared to a placebo.

Effectiveness of Antidepressants

The effectiveness of antidepressants has been a topic of debate. In a review of 74 studies, 38 showed that the drugs were effective, while 36 showed that they were not. The effectiveness of antidepressant drugs is significantly higher for individuals with severe depression compared to those with mild to moderate depression.

Understanding Reactive vs. Endogenous Depression

Mild to moderate depression is often reactive, stemming from situational problems, such as relationship issues, financial difficulties, or job stress. In these cases, psychotherapy and lifestyle changes may be sufficient to alleviate symptoms. However, severe depression is often endogenous or genetic, requiring more intensive treatment, such as antidepressant medication or brain stimulation techniques. Antidepressants can provide relief from symptoms, making it easier for individuals to make positive life changes and engage in therapy.

Ketamine Treatment

Ketamine is a relatively new treatment option for depression that has shown promising results. It involves intravenous (IV) infusions of ketamine over a period of four days. Ketamine has been found to alleviate depression within the first day of treatment, with effects lasting up to 8 to 12 months in some individuals. However, ketamine treatment is not without risks and side effects, and it is typically reserved for individuals with treatment-resistant depression.

Brain Stimulation Techniques

Brain stimulation techniques, such as electroconvulsive therapy (ECT) and vagus nerve stimulation (VNS), are used in cases of severe depression that have not responded to other treatments. ECT involves passing an electrical current through the brain to induce a brief seizure, while VNS involves stimulating the vagus nerve with electrical impulses. These techniques have been shown to be effective in alleviating depressive symptoms in some individuals.

Psychological Theories of Depression

Several psychological theories attempt to explain the development and maintenance of depression:

  • Cognitive-Behavioral Theory: This theory posits that depression results from problematic behaviors and dysfunctional thinking patterns. Negative thoughts, maladaptive beliefs, and cognitive distortions contribute to the development and maintenance of depression.

  • Behavioral Theories: According to behavioral theories, the removal of rewards, especially social rewards, can lead to depression. When individuals experience a loss of positive reinforcement, they may become withdrawn, inactive, and depressed.

Beck's cognitive theory attributes depression to maladaptive attitudes, negative self-views, and negative automatic thoughts. Individuals with depression tend to have a negative view of themselves, the world, and the future. Rumination, or dwelling on negative thoughts and feelings, and learned helplessness, the belief that one is unable to control or change their circumstances, also contribute to depression.

Therapeutic Approaches

Various therapeutic approaches are used to treat depression:

  • Cognitive-behavioral therapy (CBT)

  • Interpersonal therapy (IPT)

  • Acceptance and Commitment Therapy (ACT)

Encouraging patients to engage in previously enjoyed activities is a key therapeutic strategy. Beck's therapy involves increasing activities, challenging negative thoughts, and changing those thoughts. Acceptance and Commitment Therapy (ACT) is also used to help individuals accept their thoughts and feelings without judgment and commit to taking action towards valued goals.

Sociocultural Perspective

Social and cultural factors also play a role in the development and expression of depression. Social deficits, such as social isolation and lack of social support, can lead to depression, as was highlighted during the COVID-19 pandemic. Interpersonal psychotherapy focuses on building social skills and improving interpersonal relationships. Couples therapy can be beneficial for individuals whose depression is related to relationship issues. Culturally, depression is found worldwide, but the way it is expressed can vary across cultures. Western countries tend to show more cognitive symptoms, such as negative thoughts and feelings of worthlessness, while non-Western countries tend to show more physical symptoms, such as fatigue and body aches. Women are twice as likely to experience depression as men, due to a combination of biological differences, cultural expectations, and stressors.

Summary

Unipolar depression is a complex disorder influenced by a combination of genetic, biological, psychological, and environmental factors. The severity and timing of negative events play a crucial role in the development of depression. Developing emotional resilience in childhood is a protective factor against depression. Depression is viewed as a disorder influenced by both biology and environment and is treatable with a variety of interventions.